Author

N. Lasrado

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Research Focus:host-pathogen & immune response· 5 Organism:human· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

D. H. Barouch· 4 shared A.-r. Collier· 3 shared B. Korber· 3 shared C. Mazurek· 3 shared J. Miller· 3 shared N. Hachmann· 3 shared R. Patio· 3 shared J. Fisher· 2 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

D. H. Barouch

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86

S. Turner, G. Amirthalingam, D. Bailey, D. H. Barouch, K. R. Bewley, K. Brown, Y. R. Cao, Y.-W. Chan, S. Charlton, DOVE consortium, N. S. Coombes, B. Hallis, D. D. Ho, F. Jian, N. Lasrado, , D. J. Smith

The paper analyzes antibody neutralization data from multiple countries to assess how prior exposure to SARS-CoV-2 variants affects neutralization profiles of BA.2.86 and its descendants.

bioRxiv · Mar 27, 2024 · PreprintImmunology

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.2.86

N. Lasrado, A.-r. Collier, N. Hachmann, J. Miller, M. Rowe, E. Schonberg, S. Rodrigues, A. LaPiana, R. Patio, T. Anand, J. Fisher, C. Mazurek, R. Guan, K. Wagh, J. Theiler, , D. H. Barouch

This study evaluates the neutralization escape of the SARS-CoV-2 Omicron subvariant BA.2.86 compared to other variants, finding lower neutralization by antibodies than BA.2 but comparable to circulating variants.

bioRxiv · Sep 4, 2023Microbiology

Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters

N. Lasrado, A.-r. Collier, J. Miller, N. Hachmann, J. Liu, M. Sciacca, C. Wu, T. Anand, E. Bondzie, J. Fisher, C. Mazurek, R. Patio, O. Powers, S. Rodrigues, M. Rowe, , D. H. Barouch

This study evaluates the durability of humoral and cellular immune responses to XBB.1.5 after bivalent mRNA boosters, finding waning neutralizing antibody titers but preserved T cell responses.

bioRxiv · Jan 22, 2023 · PreprintImmunology

Substantial Neutralization Escape by the SARS-CoV-2 Omicron Variant BQ.1.1

J. Miller, N. Hachmann, A.-r. Collier, N. Lasrado, C. Mazurek, R. Patio, O. Powers, N. Surve, J. Theiler, B. Korber, D. H. Barouch

The paper shows BQ.1.1 SARS-CoV-2 variant has greater neutralization escape compared to BA.5, with lower NAb titers in vaccinated individuals.

bioRxiv · Nov 1, 2022 · PreprintImmunology

Dissecting the Cellular Landscape and Transcriptome Network in Viral Myocarditis by Single-Cell RNA Sequencing

N. Lasrado, N. Borcherding, R. Arumugam, T. K. Starr, J. Reddy

This study uses single-cell RNA sequencing to analyze heart cells from healthy and myocarditic mice, identifying changes in immune and non-immune cell populations and their transcriptomic roles in viral myocarditis.

bioRxiv · May 16, 2021Immunology

Evidence for anti-viral effects of complete Freunds adjuvant in the mouse model of enterovirus infection

A. Gangaplara, C. Massilamany, N. Lasrado, D. Steffen, J. Reddy

The paper shows that complete Freund's adjuvant (CFA) alone can protect mice from CVB3-induced myocarditis and pancreatitis, suggesting its potential as an adjuvant for viral vaccines.

bioRxiv · May 27, 2020Immunology